Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
Lucy Mosscrop, Thomas Williams, John S. Tregoning
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 589-590
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 16, pp. 1465-1477
Closed Access | Times Cited: 347
Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022
Arindam Nandi, Simone Pecetta, David E. Bloom
EClinicalMedicine (2023) Vol. 57, pp. 101848-101848
Open Access | Times Cited: 133
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review
Yu-Chuan Chuang, Kuan-Pei Lin, Lian Wang, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 661-675
Open Access | Times Cited: 88
Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study
Ulrikka Nygaard, Ulla Birgitte Hartling, Jens Peter Nielsen, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 3, pp. 171-179
Open Access | Times Cited: 77
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps
Ricardo de Amorim Corrêa, Francisco Arancibia, Renato de Ávila Kfouri, et al.
Pulmonary Therapy (2024) Vol. 10, Iss. 1, pp. 1-20
Open Access | Times Cited: 7
Going Viral—RSV as the Neglected Adult Respiratory Virus
Bethany Busack, Andrew F. Shorr
Pathogens (2022) Vol. 11, Iss. 11, pp. 1324-1324
Open Access | Times Cited: 28
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65
Robert Buynak, Kevin D. Cannon, David DeAtkine, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1789-1805
Open Access | Times Cited: 5
Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS‐CoV‐2 emergence
Marta Luisa Ciofi degli Atti, Caterina Rizzo, Carmen D’Amore, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 3
Open Access | Times Cited: 15
Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus‐related diseases: A systematic review and meta‐analysis
Yuping Duan, Mingyue Jiang, Qiangru Huang, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 13
Respiratory viruses in the pre and post‐pandemic periods in an Italian tertiary hospital
Flavio De Maio, Barbara Fiori, Delia Mercedes Bianco, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 11
IL-1α is required for T cell-driven weight loss after respiratory viral infection
Ziyin Wang, Leah Cuthbertson, Chubicka Thomas, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 272-287
Open Access | Times Cited: 3
Effect of the COVID-19 pandemic on the pediatric infectious disease landscape
Moshe Shmueli, Idan Lendner, Shalom Ben‐Shimol
European Journal of Pediatrics (2023) Vol. 183, Iss. 3, pp. 1001-1009
Open Access | Times Cited: 9
Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China
Ying Li, Zhiyong Wu, Yi Yan, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 6-12
Open Access | Times Cited: 9
Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance
Lance Presser, Willem M.R. van den Akker, Adam Meijer, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. Supplement_1, pp. S34-S39
Open Access | Times Cited: 8
Virus-mimicking nanosystems: from design to biomedical applications
Haoyang Liu, Xiao Li, Zhi‐Gang Wang, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8481-8499
Closed Access | Times Cited: 7
Human parechovirus encephalitis in infants: a retrospective single-center study (2017–2022)
Muayad Alali, Kiet Tat, Shannon Hamilton, et al.
European Journal of Pediatrics (2023) Vol. 182, Iss. 10, pp. 4457-4465
Closed Access | Times Cited: 6
Metabolic reprograming and increased inflammation by cadmium exposure following early-life respiratory syncytial virus infection: the involvement of protein S-palmitoylation
Zachery Jarrell, Choon‐Myung Lee, Ki‐Hye Kim, et al.
Toxicological Sciences (2023) Vol. 197, Iss. 2, pp. 186-196
Open Access | Times Cited: 6
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
Ipshita Menon, Smital Patil, Priyal Bagwe, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 866-866
Open Access | Times Cited: 5
Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children
Rafaela Pires da Silva, Bibiana Liberman Thomé, Ana Paula Duarte de Souza
Biology (2023) Vol. 12, Iss. 9, pp. 1223-1223
Open Access | Times Cited: 5
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
Marina Antillón, Xiao Li, Lander Willem, et al.
PLoS Medicine (2023) Vol. 20, Iss. 7, pp. e1004250-e1004250
Open Access | Times Cited: 5
Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic
Dinah V. Parums
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 8
Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland
Marissa K. Hetrich, Jennifer Oliva, Kimberli Wanionek, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1349-1357
Open Access | Times Cited: 6
Temporal Shift of the Respiratory Syncytial Virus Epidemic Peak for the Years 2020–2023 in Marseille, Southern France
Lucille Claire de Maria, Philippe Colson, Aurélie Morand, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1671-1671
Open Access | Times Cited: 3
RSV replication modifies the XBP1s binding complex on the IRF1 upstream enhancer to potentiate the mucosal anti-viral response
Dianhua Qiao, Xiaofang Xu, Yueqing Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Co-detection of respiratory syncytial virus with other respiratory viruses across all age groups before and during the COVID-19 pandemic
Haya Hayek, Justin Z. Amarin, Yasmeen Z. Qwaider, et al.
Frontiers in Virology (2023) Vol. 3
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top